Alarmin function of cathelicidin antimicrobial peptide ll37 through il-36γ induction in human epidermal Keratinocytes

Journal of Immunology

Volumn 193, Issue 10, 2014, Pages 5140-5148

  Li, Na ^a   Yamasaki, Kenshi ^a   Saito, Rumiko ^a,b   Fukushi Takahashi, Sawako ^a   Shimada Omori, Ryoko ^a   Asano, Masayuki ^a   Aiba, Setsuya ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COMPLEMENTARY DNA; CXCL1 CHEMOKINE; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1; INTERLEUKIN 36; INTERLEUKIN 36 RECEPTOR; INTERLEUKIN 36GAMMA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PERTUSSIS TOXIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CALCIUM; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE; CHEMOKINE; CULTURE MEDIUM; IL36G PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE INHIBITOR;

ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DERMATITIS; DNA MICROARRAY; GENE; GENE CLUSTER; HUMAN; HUMAN CELL; IL36G GENE; INNATE IMMUNITY; KERATINOCYTE; NEWBORN; PROTEIN FUNCTION; PROTEIN INDUCTION; PSORIASIS; SIGNAL TRANSDUCTION; SKIN DEFECT; AGONISTS; AMINO ACID SEQUENCE; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PRIMARY CELL CULTURE; SKIN;

AMINO ACID SEQUENCE; CALCIUM; CATHELICIDINS; CHEMOKINES; CULTURE MEDIA; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; KERATINOCYTES; MOLECULAR SEQUENCE DATA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERTUSSIS TOXIN; PRIMARY CELL CULTURE; PROTEIN KINASE INHIBITORS; PSORIASIS; RECEPTORS, CYTOKINE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SKIN;

EID: 84910128466     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302574     Document Type: Article

References (44)

1. Schauber, J., R. A. Dorschner, K. Yamasaki, B. Brouha, and R. L. Gallo. 2006. Control of the innate epithelial antimicrobial response is cell-Type specific and dependent on relevant microenvironmental stimuli. Immunology 118: 509-519.
2. López-García, B., P. H. Lee, K. Yamasaki, and R. L. Gallo. 2005. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J. Invest. Dermatol. 125: 108-115.
3. Howell, M. D., J. F. Jones, K. O. Kisich, J. E. Streib, R. L. Gallo, and D. Y. Leung. 2004. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J. Immunol. 172: 1763-1767.
4. Murakami, M., B. Lopez-Garcia, M. Braff, R. A. Dorschner, and R. L. Gallo. 2004. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172: 3070-3077.
5. Yamasaki, K., and R. L. Gallo. 2008. Antimicrobial peptides in human skin disease. Eur. J. Dermatol. 18: 11-21.
6. Oppenheim, J. J., and D. Yang. 2005. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17: 359-365.
7. Morizane, S., K. Yamasaki, B. Mühleisen, P. F. Kotol, M. Murakami, Y. Aoyama, K. Iwatsuki, T. Hata, and R. L. Gallo. 2012. Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. J. Invest. Dermatol. 132: 135-143.
8. Lande, R., J. Gregorio, V. Facchinetti, B. Chatterjee, Y. H. Wang, B. Homey, W. Cao, Y. H.Wang, B. Su, F. O. Nestle, et al. 2007. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564-569.
9. Kandler, K., R. Shaykhiev, P. Kleemann, F. Klescz, M. Lohoff, C. Vogelmeier, and R. Bals. 2006. The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int. Immunol. 18: 1729-1736.
10. Koczulla, R., G. von Degenfeld, C. Kupatt, F. Krötz, S. Zahler, T. Gloe, K. Issbrücker, P. Unterberger, M. Zaiou, C. Lebherz, et al. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111: 1665-1672.
11. Bromley, S. K., T. R. Mempel, and A. D. Luster. 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9: 970-980.
12. Zanetti, M. 2004. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75: 39-48.
13. Braff, M. H., M. A. Hawkins, A. Di Nardo, B. Lopez-Garcia, M. D. Howell, C. Wong, K. Lin, J. E. Streib, R. Dorschner, D. Y. Leung, and R. L. Gallo. 2005. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J. Immunol. 174: 4271-4278.
14. Filewod, N. C., J. Pistolic, and R. E. Hancock. 2009. Low concentrations of LL-37 alter IL-8 production by keratinocytes and bronchial epithelial cells in response to proinflammatory stimuli. FEMS Immunol. Med. Microbiol. 56: 233-240.
15. Yu, J., N. Mookherjee, K. Wee, D. M. Bowdish, J. Pistolic, Y. Li, L. Rehaume, and R. E. Hancock. 2007. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J. Immunol. 179: 7684-7691.
16. Dorschner, R. A., V. K. Pestonjamasp, S. Tamakuwala, T. Ohtake, J. Rudisill, V. Nizet, B. Agerberth, G. H. Gudmundsson, and R. L. Gallo. 2001. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 117: 91-97.
17. Schauber, J., R. A. Dorschner, A. B. Coda, A. S. Büchau, P. T. Liu, D. Kiken, Y. R. Helfrich, S. Kang, H. Z. Elalieh, A. Steinmeyer, et al. 2007. Injury en-hances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 117: 803-811.
18. Frohm, M., B. Agerberth, G. Ahangari, M. Stâ hle-Bäckdahl, S. Lidén, H. Wigzell, and G. H. Gudmundsson. 1997. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272: 15258-15263.
19. Yamasaki, K., A. Di Nardo, A. Bardan, M. Murakami, T. Ohtake, A. Coda, R. A. Dorschner, C. Bonnart, P. Descargues, A. Hovnanian, et al. 2007. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med. 13: 975-980.
20. Ong, P. Y., T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R. L. Gallo, and D. Y. Leung. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347: 1151-1160.
21. Yamasaki, K., and R. L. Gallo. 2009. The molecular pathology of rosacea. J. Dermatol. Sci. 55: 77-81.
22. Saito, R., S. Hirakawa, H. Ohara, M. Yasuda, T. Yamazaki, S. Nishii, and S. Aiba. 2011. Nickel differentially regulates NFAT and NF-κB activation in T cell signaling. Toxicol. Appl. Pharmacol. 254: 245-255.
23. Takahashi, T., Y. Kimura, K. Niwa, Y. Ohmiya, T. Fujimura, K. Yamasaki, and S. Aiba. 2013. In vivo imaging demonstrates ATP release from murine keratinocytes and its involvement in cutaneous inflammation after tape stripping. J. Invest. Dermatol. 133: 2407-2415.
24. Lai, Y., and R. L. Gallo. 2009. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30: 131-141.
25. Jensen, L. E. 2010. Targeting the IL-1 family members in skin inflammation. Curr. Opin. Investig. Drugs 11: 1211-1220.
26. Mabuchi, T., T. W. Chang, S. Quinter, and S. T. Hwang. 2012. Chemokine receptors in the pathogenesis and therapy of psoriasis. J. Dermatol. Sci. 65: 4-11.
27. Di Cesare, A., P. Di Meglio, and F. O. Nestle. 2009. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J. Invest. Dermatol. 129: 1339-1350.
28. Miller, L. S. 2008. Toll-like receptors in skin. Adv. Dermatol. 24: 71-87.
29. Sims, J. E., and D. E. Smith. 2010. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10: 89-102.
30. Towne, J. E., K. E. Garka, B. R. Renshaw, G. D. Virca, and J. E. Sims. 2004. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J. Biol. Chem. 279: 13677-13688.
31. Blumberg, H., H. Dinh, E. S. Trueblood, J. Pretorius, D. Kugler, N. Weng, S. T. Kanaly, J. E. Towne, C. R. Willis, M. K. Kuechle, et al. 2007. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J. Exp. Med. 204: 2603-2614.
32. Johnston, A., X. Xing, A. M. Guzman, M. Riblett, C. M. Loyd, N. L. Ward, C. Wohn, E. P. Prens, F. Wang, L. E. Maier, et al. 2011. IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J. Immunol. 186: 2613-2622.
33. Onoufriadis, A., M. A. Simpson, A. E. Pink, P. Di Meglio, C. H. Smith, V. Pullabhatla, J. Knight, S. L. Spain, F. O. Nestle, A. D. Burden, et al. 2011. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am. J. Hum. Genet. 89: 432-437.
34. Marrakchi, S., P. Guigue, B. R. Renshaw, A. Puel, X. Y. Pei, S. Fraitag, J. Zribi, E. Bal, C. Cluzeau, M. Chrabieh, et al. 2011. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N. Engl. J. Med. 365: 620-628.
35. Ramadas, R. A., S. L. Ewart, B. D. Medoff, and A. M. LeVine. 2011. Interleukin-1 family member 9 stimulates chemokine production and neutrophil influx in mouse lungs. Am. J. Respir. Cell Mol. Biol. 44: 134-145.
36. Chustz, R. T., D. R. Nagarkar, J. A. Poposki, S. Favoreto, Jr., P. C. Avila, R. P. Schleimer, and A. Kato. 2011. Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 45: 145-153.
37. Milligan, G., J. Lopez-Gimenez, S.Wilson, and J. J. Carrillo. 2004. Selectivity in the oligomerisation of G protein-coupled receptors. Semin. Cell Dev. Biol. 15: 263-268.
38. Milligan, G. 2001. Oligomerisation of G-protein-coupled receptors. J. Cell Sci. 114: 1265-1271.
39. Takesono, A., M. J. Cismowski, C. Ribas, M. Bernard, P. Chung, S. Hazard III, E. Duzic, and S. M. Lanier. 1999. Receptor-independent activators of heterotrimeric G-protein signaling pathways. J. Biol. Chem. 274: 33202-33205.
40. Cismowski, M. J., A. Takesono, M. L. Bernard, E. Duzic, and S. M. Lanier. 2001. Receptor-independent activators of heterotrimeric G-proteins. Life Sci. 68: 2301-2308.
41. Sandgren, S., A. Wittrup, F. Cheng, M. Jönsson, E. Eklund, S. Busch, and M. Belting. 2004. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J. Biol. Chem. 279: 17951-17956.
42. Sanmiguel, J. C., F. Olaru, J. Li, E. Mohr, and L. E. Jensen. 2009. Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways. Cell. Signal. 21: 685-694.
43. Ohta, Y., Y. Hamada, and K. Katsuoka. 2001. Expression of IL-18 in psoriasis. Arch. Dermatol. Res. 293: 334-342.
44. Carrier, Y., H. L. Ma, H. E. Ramon, L. Napierata, C. Small, M. O'Toole, D. A. Young, L. A. Fouser, C. Nickerson-Nutter, M. Collins, et al. 2011. Interregulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J. Invest. Dermatol. 131: 2428-2437.